JP2023552791A5 - - Google Patents
Info
- Publication number
- JP2023552791A5 JP2023552791A5 JP2023534648A JP2023534648A JP2023552791A5 JP 2023552791 A5 JP2023552791 A5 JP 2023552791A5 JP 2023534648 A JP2023534648 A JP 2023534648A JP 2023534648 A JP2023534648 A JP 2023534648A JP 2023552791 A5 JP2023552791 A5 JP 2023552791A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyldiyl
- peg
- alkyl
- immunocomplex
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063124421P | 2020-12-11 | 2020-12-11 | |
| US63/124,421 | 2020-12-11 | ||
| PCT/US2021/062833 WO2022125915A1 (en) | 2020-12-11 | 2021-12-10 | Anti-her2 immunoconjugates, and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023552791A JP2023552791A (ja) | 2023-12-19 |
| JP2023552791A5 true JP2023552791A5 (cg-RX-API-DMAC7.html) | 2024-12-05 |
Family
ID=79425413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023534648A Withdrawn JP2023552791A (ja) | 2020-12-11 | 2021-12-10 | 抗her2免疫複合体、及びその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240042050A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4259211A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023552791A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116897054A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3200320A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022125915A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3200056A1 (en) | 2020-12-11 | 2022-06-16 | Shelley Erin ACKERMAN | Anti-her2 immunoconjugates, and uses thereof |
| WO2023154318A1 (en) * | 2022-02-09 | 2023-08-17 | Bolt Biotherapeutics, Inc. | Anti-tr0p2, aminobenzazepine immunoconjugates, and uses thereof |
| WO2024173387A1 (en) | 2023-02-14 | 2024-08-22 | Bolt Biotherapeutics, Inc. | Aza-benzazepine immunoconjugates, and uses thereof |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3101690B2 (ja) | 1987-03-18 | 2000-10-23 | エス・ビィ・2・インコーポレイテッド | 変性抗体の、または変性抗体に関する改良 |
| WO1989006692A1 (en) | 1988-01-12 | 1989-07-27 | Genentech, Inc. | Method of treating tumor cells by inhibiting growth factor receptor function |
| EP0590058B1 (en) | 1991-06-14 | 2003-11-26 | Genentech, Inc. | HUMANIZED Heregulin ANTIBODy |
| WO1994004679A1 (en) | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
| US6800738B1 (en) | 1991-06-14 | 2004-10-05 | Genentech, Inc. | Method for making humanized antibodies |
| ATE370961T1 (de) | 1998-05-06 | 2007-09-15 | Genentech Inc | Reinigung von antikörpern durch ionenaustauschchromatographie |
| US6949245B1 (en) | 1999-06-25 | 2005-09-27 | Genentech, Inc. | Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies |
| AU5345901A (en) | 2000-04-13 | 2001-10-30 | Univ Rockefeller | Enhancement of antibody-mediated immune responses |
| TR201808537T4 (tr) | 2004-09-23 | 2018-07-23 | Genentech Inc | Sistein değiştirilmiş antikorlar ve konjugatlar. |
| US20070014795A1 (en) | 2004-12-30 | 2007-01-18 | Dhodapkar Madhav V | Compositions and methods for enhanced dendritic cell maturation and function |
| AU2006312148B2 (en) | 2005-11-07 | 2012-04-12 | The Rockefeller University | Reagents, methods and systems for selecting a cytotoxic antibody or variant thereof |
| PE20090245A1 (es) | 2007-05-08 | 2009-03-17 | Genentech Inc | Anticuerpos anti-muc16 disenados con cisteina y conjugados de anticuerpos y farmacos |
| BRPI0818780A2 (pt) | 2007-10-19 | 2015-04-22 | Genentech Inc | Anticorpo anti-tenb2 planejados por cisteína e conjugados de medicamento com anticorpos |
| EP2640727B1 (en) | 2010-11-17 | 2015-05-13 | Genentech, Inc. | Alaninyl maytansinol antibody conjugates |
| JP6805142B2 (ja) | 2014-11-21 | 2020-12-23 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | Cd73に対する抗体およびその使用 |
| EP3849971A2 (en) * | 2018-09-12 | 2021-07-21 | Silverback Therapeutics, Inc. | Substituted benzazepine compounds, conjugates, and uses thereof |
| JP2022537158A (ja) * | 2019-06-13 | 2022-08-24 | ボルト バイオセラピューティクス、インコーポレーテッド | アミノベンズアゼピン化合物、イムノコンジュゲート、及びそれらの使用 |
| EP3983080A1 (en) * | 2019-06-13 | 2022-04-20 | Bolt Biotherapeutics, Inc. | Macromolecule-supported aminobenzazepine compounds |
| CA3176626A1 (en) * | 2020-05-08 | 2021-11-11 | David Dornan | Elastase-substrate, peptide linker immunoconjugates, and uses thereof |
-
2021
- 2021-12-10 JP JP2023534648A patent/JP2023552791A/ja not_active Withdrawn
- 2021-12-10 US US18/038,897 patent/US20240042050A1/en active Pending
- 2021-12-10 EP EP21841073.6A patent/EP4259211A1/en not_active Withdrawn
- 2021-12-10 CA CA3200320A patent/CA3200320A1/en active Pending
- 2021-12-10 WO PCT/US2021/062833 patent/WO2022125915A1/en not_active Ceased
- 2021-12-10 CN CN202180092533.5A patent/CN116897054A/zh active Pending